Search results
Recommendations from the AML molecular MRD expert advisory board - Leukemia
Nature· 5 days agoThe standard-of-care treatment for patients with acute myeloid leukemia (AML) is being challenged by new classes of targeted therapies ...
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells - Leukemia
Nature· 6 days agoMyelodysplastic syndromes (MDS) are malignant bone marrow disorders characterized by ineffective hematopoiesis leading to refractory cytopenias and an increased risk of progression to
Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
WROC Rochester· 5 days agoOral presentation of final five-year results from the registrational Phase 2 trial in R/R mIDH1 AML patients reinforces REZLIDHIA® (olutasidenib) efficacy in heavily pretreated ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoCAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market to Register Stunning Growth by 2032, Predicts DelveInsight | Key Companies - AUTOLUS THERAPEUTICS ...
ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug...
FOX 5 San Diego· 5 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that its ...
GlycoMimetics (NASDAQ:GLYC) Now Covered by Analysts at StockNews.com
ETF DAILY NEWS· 5 days agoStockNews.com assumed coverage on shares of GlycoMimetics (NASDAQ:GLYC – Free Report) in a research note released on Wednesday. The firm issued a sell rating on the biotechnology company’s stock ...
7 Biotech Stocks to Put on Your Breakthrough Radar
InvestorPlace· 22 hours agoFor those seeking to decipher best speculative opportunities in the market, biotech stocks with breakthrough potential may offer plenty of firepower....
All over the body: Here are the key clinical trials from Bay Area firms - San Francisco Business...
The Business Journals· 4 days agoSince the turn of the millennium, Bay Area organizations and researchers have launched more than 300...
Innovative Techniques Open New Avenues in Drug Dis | Newswise
Newswise· 5 days agoVolume 29, Issue 2 of SLAS Discovery features two review articles, six original research articles...
NCI-MATCH Precision Medicine Clinical Trial
National Cancer Institute· 5 days agoNCI-MATCH, also known as MATCH, is a precision medicine cancer treatment clinical trial that sought to find out if treating cancer based on specific...